Regulatory uncertainty and the associated business risk for emerging technologies

Journal of Nanoparticle Research

Volumn 13, Issue 4, 2011, Pages 1513-1520

  Hoerr, Robert A ^a  

^a Nanocopoeia Inc   (United States)

Author keywords

Development cost; Emerging technology; Governance; Investment risk; Nanotechnology; Regulatory oversight; Regulatory uncertainty; Venture capital

Indexed keywords

DEVELOPMENT COSTS; EMERGING TECHNOLOGY; GOVERNANCE; INVESTMENT RISK; REGULATORY OVERSIGHT; REGULATORY UNCERTAINTY; VENTURE CAPITAL;

INVESTMENTS; NANOSTRUCTURED MATERIALS; TECHNOLOGY TRANSFER;

HEALTH RISKS;

NANOMATERIAL;

COMMERCIAL PHENOMENA; COST BENEFIT ANALYSIS; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; HEALTH; HISTORY; HUMAN; INVESTMENT; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT;

EID: 79956143946     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-011-0260-z     Document Type: Review

References (16)

1. Adams CP, Brantner VV (2006) Estimating the cost of new drug development: is it really $802 million? Health Aff 25:420-428
2. Alesandri TM, Ford DN, Lander DM, Leggio KB, Taylor M (2004) Managing risk and uncertainty in complex capital projects. Q Rev Econ Finance 44:761-767
3. Baeyens K, Vanacker T, Manigart S (2006) Venture capitalists' selection process: the case of biotechnology proposals. Int J Technol Manag 34:28-46
4. Bayer JC, Norton GW, Falck-Zepeda JB (2010) Cost of compliance with biotechnology regulation in the Philippines: implications for developing countries. AgBioForum 13:53-62
5. Chen S-S, Chung T-Y, Ho KW (2007) Intra-industry effects of delayed new product introductions. Rev Pac Basin Financ Mark Policies 10:415-443 (Pubitemid 47423460)
6. Cohen LP (1992) Biotech Stocks are Caught in Centocor Downdraft. Wall Street J, April 16, C1
7. Food and Drug Administration (FDA) (2007a) Nanotechnology task force report. http://www.fda.gov/ScienceResearch/SpecialTopics/Nanotechnology/ NanotechnologyTaskForceReport2007/default.htm. Accessed 31 August 2010
8. Food and Drug Administration (FDA) (2007b) Draft Guidance for Industry, Clinical Laboratories, and FDA Staff: In Vitro Diagnostic Multivariate Index Assays. http://www.fda.gov/cdrh/oivd/guidance/1610.pdf. Accessed 30 August 2010
9. Heesen MG (2010) Letter to Margaret Hamburg, FDA Commissioner, from National Venture Capital Association President Mark Heesen regarding novel therapies and technologies. http://www.nvca.org/index.php?option=com- docman&task=doc-download&gid=549&Itemid=93. Accessed 30 August 2010
10. Hendricks KB, Singhal VR (1997) Delays in new product introductions and the market value of the firm: the consequences of being late to the market. Manag Sci 43:422-436 (Pubitemid 127569848)
11. Hoerr RA, Gupta A, Matuszewski M (2009) Developing practices for safe handling of nanoparticles and nanomaterials in a development-stage enterprise: a practical guide for research and development organizations. In: Webster TJ (ed) Safety of nanoparticles: from manufacturing to medical applications. Springer, New York
12. National Science Foundation (NSF) (2008) National Patterns of R&D Resources: 2008 Data Update. Detailed Statistical Tables, NSF 10-314, March 2010. http://www.nsf.gov/statistics/nsf10314/pdf/nsf10314.pdf. Accessed 30 August 2010
13. Oberdörster G (2010) Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Int Med 267:89-105
14. Price W (2007) Introduction to venture capital. http://www.slideshare. net/pricew/introduction-to-venture-capital. Accessed 31 August 2010
15. Ramachandran G, Wolf SM, Paradise J, Kuzma J, Hall R, Kokkoli E, Fatehi L (2011) Recommendations for oversight of nanobiotechnology: dynamic oversight for complex and convergent technology. J Nanopart Res. doi: 10.1007/s11051-011- 0233-2
16. Sjöö K (2008) The influence of uncertainty on venture capital investments in renewable energy technology: an exploratory study. Master thesis, University of Oslo, Norway. http://www.duo.uio.no/publ/tik/2008/85712/ Uppsatsen.pdf. Accessed 31 August 2010